Company Name or Ticker Symbol
Search for other Categories

Tesaro, Inc.  (TSRO)
Other Ticker:  
    Sector  Healthcare    Industry Major Pharmaceutical Preparations

TSRO's Revenue Year on Year Growth by Quarter and Year

Tesaro,'s Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
TSRO Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 4.23 0.23 -
III Quarter September - 3.73 0.09 -
II Quarter June - 36.56 - -
I Quarter March 3.07 0.31 - -
FY   3.07 44.83 0.32 -

Financial Statements
Tesaro,'s first quarter 2017 Revenue $ 3.07 millions TSRO's Income Statement
Tesaro,'s first quarter 2016 Revenue $ 0.31 millions Quarterly TSRO's Income Statement
TSRO's Growth by Division See TSRO's Growth by Segment

TSRO Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 1739.13 % - -
III Quarter September - 4044.44 % - -
II Quarter June - - - -
I Quarter March 891.29 % - - -
FY   - 13909.38 % - -

TSRO Revenue Growth Comment
Tesaro, Inc. reported Revenue surge of 891.29% year on year in the first quarter, to $ 3.07 millions, this is lower than Tesaro, Inc.'s recent average Revenue surge of 2275.1%.

Looking into first quarter results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Revenue growth. While Tesaro, Inc.' s Revenue doubling of 891.29% ranks overall at the positon no. 59 in the first quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #14
S&P 500 #59
Revenue Y/Y Growth Statistics
High Average Low
4187.36 % 2275.1 % 900.98 %
(Sep 30 2016)   (Mar 31 2017)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TSRO's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for TSRO's Competitors
Revenue Growth for Tesaro,'s Suppliers
Revenue Growth for TSRO's Customers

You may also want to know
TSRO's Annual Growth Rates TSRO's Profitability Ratios TSRO's Asset Turnover Ratio TSRO's Dividend Growth
TSRO's Roe TSRO's Valuation Ratios TSRO's Financial Strength Ratios TSRO's Dividend Payout Ratio
TSRO's Roa TSRO's Inventory Turnover Ratio TSRO's Growth Rates TSRO's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Acura Pharmaceuticals, Inc  1,112.95 %$ 1,112.946 millions
Sophiris Bio Inc.  920.00 %$ 920.000 millions
Tesaro, Inc.  900.98 %$ 900.977 millions
Biodelivery Sciences International Inc  869.67 %$ 869.671 millions
Innovus Pharmaceuticals, Inc.  865.70 %$ 865.697 millions
Biocept Inc  660.30 %$ 660.298 millions
Geovax Labs, Inc.  521.29 %$ 521.292 millions

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com